Table 2.
Year | No. of registered patients/yr | Accumulated No. of patients |
---|---|---|
2012 | 717 | 717 |
2013 | 579 | 1,296 |
2014 | 247 | 1,543 |
2015 | 343 | 1,886 |
2016 | 310 | 2,196 |
The numbers in the left column are the number of registered patients in each year whereas those in the right column are the cumulative number of patients at the end of each year. Since the initiation of LG Growth Study (LGS) registry on 9 November 2011, patients in need of recombinant human growth hormone have been continually registered in the LGS registry.